Sorrento Therapeutics Inc

Overview

Sorrento Therapeutics Inc (Sorrento) is a biopharmaceutical company that focuses on developing therapeutics for the treatment of cancer, osteoarthritis and autoimmune diseases. The company’s immunotherapy pipeline portfolio consists of a CD38 CAR-T, CD38 ADC, CD38 DAR-T and Sephrehvir for treatment of cancer. Sorrento is also investigating COVID19 programs which include Coviguard, Covidrops and Covishield, among others for the treatment of COVID-19. Its marketed products include ZTlido, a lidocaine topical system for the treatment of postherpetic neuralgia (PHN). The company works in collaboration with biopharmaceutical companies and academic institutions to develop novel immunotherapies. Sorrento is headquartered in San Diego, California, the US.
Key Stats
Address
4955 Directors Pl, SAN DIEGO, California
Headquarters

United States of America

Contact

1 858 2034100

No of Employees

502

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

SRNE [NASD]

Revenue (2020)

$40 m

27.3% (2020 vs 2019)
Net Income (2020)

$-298 m

-2% (2020 vs 2019)
Net Profit Margin

-746 %

19.7% (2020 vs 2019)
Market Cap *

$2,409 m

EPS *

$-1.3

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Sorrento Therapeutics IncExelixis IncBioNTech SEAdaptimmune Therapeutics Plc
Key Information
Headquarters United States of America United States of America Germany United Kingdom
Headquarter City SAN DIEGO ALAMEDA MAINZ ABINGDON
Headquarter State/Province California California - -
No. of Employees 502 773 2,500 462
Entity Type Public Public Public Public

Products & Services

Sorrento is a cancer therapeutic service provider. The key products offered by the company include the following:

Products
  • Products :
  • Marketed:
  • ZTlido - Postherpetic neuralgia (PHN),
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • API Biologics (Cell, Gene, Vaccine and Virus)
  • API Biologics (Protein and Peptide)
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Brands
  • ZTlido
  • G-MAB
  • Sofusa
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Najjam Asghar Senior Vice President; Chief Financial Officer Senior Management 2020 40 Mr. Najjam Asghar has been the Senior Vice President and the Chief Financial Officer of the company since August 2020....
Henry Ji, Ph.D. Chairman; Chief Executive Officer; President Executive Board 2012 56 Mr. Henry Ji has been the Chairman, Chief Executive Officer and President of the company since 2012. Prior to this,...
Mike Royal, M.D. Chief Medical Officer Senior Management - - Dr. Mike Royal has been the Chief Medical Officer of the company. Prior to this, he served as the Chief...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Regulatory Approval In May, the company announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to…
2021 Regulatory Approval In June, the company received approval from the UK Regulatory Agency to conduct a phase…
2021 Regulatory Approval In April, the company announced to secure the US FDA approval to proceed with phase…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Bioserv Corp

Address

5340 Eastgate Mall, San Diego
United States of America

Telephone

1 858 4503123

Website

www.bioservamerica.com
Concortis Biosystems Corp

Address

Suite N, 11760 Sorrento Valley, San Diego
United States of America

Telephone

1 858 8768408

Website

www.concortis.com
Virttu Biologics Ltd

Address

P.O Box 1716, Glasgow
United Kingdom

Telephone

44 141 4451716

Website

www.virttu.com
Semnur Pharmaceuticals Inc

Address

#100, 301 N Whisman Rd, Mountain View
United States of America

Telephone

1 650 5164310

Website

www.semnurpharma.com
Scilex Pharmaceuticals Inc

Address

Suite 300, 301 Lindenwood Drive, San Diego
United States of America

Telephone

1 610 6445352

Website

www.scilexpharma.com
Centre Technologies Inc

Address

Suite 200, 16801 Greenspoint Park Drive, Houston
United States of America

Telephone

1-281-506-2480

Website

www.centretechnologies.com
LA Cell Inc

Address

9380 Judicial Drive, San Diego
United States of America

Telephone

1 504 5985246

Levena Biopharma US Inc

Address

Suite 300, 4955 Directors Place, San Diego
United States of America

Telephone

1 858 2034200

Website

www.levenabiopharma.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
24 Aug 2021 Sorrento Therapeutics Exercises Option Agreement with Texas A&M University System (TAMUS) for MPRO Inhibitors Against COVID-19 Licensing Agreement Sorrento Therapeutics Inc Texas A&M University System
10 Aug 2021 Sorrento Therapeutics to Enter into Licensing Agreement with Dyadic International for COVID-19 Vaccines and Therapeutics Licensing Agreement Sorrento Therapeutics Inc Dyadic International Inc
05 Aug 2021 Aardvark Therapeutics Raises USD29 Million in Series B Financing Venture Financing Premier Partners LLC; Korea Omega Investment Finance; Vickers Venture Partners; Sorrento Therapeutics Inc; Foundation for Prader Willi Research Inc; BNH Investment LLC Aardvark Therapeutics Inc
09 Mar 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
01 Mar 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
15 Dec 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

70

Active Jobs

27

Posted

24

Closed

Job Trends

Latest Jobs

Job title Company Country
Associate Director/Director, Process Development Sorrento Therapeutics Inc United States
Manager, Clinical Operations (2 Openings) Sorrento Therapeutics Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar